All Resources

Access to Medicine • July 06, 2022

Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response

Learn more|View

Access to Medicine • February 12, 2022

Optimizing Patient Access to Precision Therapies: Preparing for the Emerging Era of Advanced Testing

Learn more|View

Access to Medicine • February 05, 2022

Bluesky Project

Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…

Learn more|View

Private Drug Coverage • August 01, 2021

Cost Drivers: Analysis of Private Drug Plans in Canada 2021

Learn more|View

Economic Impact • May 30, 2021

The Canadian Research and Development Pharmaceutical Sector

Learn more|View

Vaccine Equity • April 30, 2021

Standing Committee on International Trade (CIIT) study of Canada’s International Trade and Investment Policy

Learn more|View

Drugs for Rare Diseases (DRD) • March 26, 2021

Towards a Value-based and Pan-Canadian Rare Disease Strategy

Learn more|View

Access to Medicine • August 20, 2020

IMC and BTC joint response to CADTH’s transparency consultation

Learn more|View

Patented Medicine Prices Review Board (PMPRB) • February 14, 2020

IMC Response to PMPRB Draft Guidelines

Learn more|View

January 30, 2020

2019 Annual Report

Learn more|View

September 27, 2019

Note for guidance on patient support programs and medical practice activities

Learn more|View

June 30, 2019

Cost Drivers Analysis of Private Drug Plans in Canada 2016-2018

Learn more|View